Author: sHq_LoGiNz

NEWARK, Del., Feb. 19, 2026 /PRNewswire/ — Future Market Insights (FMI) states that the biodegradable packaging market is forecast to reach USD 13.4 billion in 2026 and is projected to expand at a 6.1% CAGR through 2036, pushing industry value beyond USD 24.2 billion by the end of the assessment period. FMI attributes this growth to a structural shift in global legislative frameworks targeting single-use plastics, alongside accelerating adoption of certified compostable formats and improving end-of-life infrastructure.

Future Market Insights (FMI) analysis highlights that the increasing availability of industrial composting facilities—growing by about 15% annually in developed regions—is strengthening the lifecycle viability of compostable polymers. In parallel, manufacturers are seeing 20–25% surcharge willingness from consumers for “green” packaging, encouraging brands to shift from petrochemical plastics to bio-based alternatives even as agricultural feedstock costs remain higher.

Quick Stats: Biodegradable Packaging Market (FMI)

• Industry Value (2026): USD 13.4 billion
• Forecast Value (2036): USD 24.2 billion
• Forecast CAGR (2026–2036): 6.1%
• Leading Form: PLA-based packaging (41%)
• Leading End Use: Food packaging (40.0%)
• Leading Functionality: Home compostable (42.0%)
• Key Growth Regions: China, India, Germany
• Key Players: NatureWorks LLC, BASF SE, Novamont S.p.A., Corbion N.V., Total Corbion PLA, Biome Bioplastics Limited, Danimer Scientific, Inc., Futamura Chemical Co., Ltd., Plastipak Holdings, Inc.

Get Access of Free Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-323 

The biodegradable packaging market spans packaging formats made from materials designed to biodegrade under defined conditions, including PLA-based, starch-based, PHA-based, and cellulose-based solutions. Applications covered include food, beverage, personal care, pharmaceutical, and industrial packaging, serving end users across retail & consumer goods, food service, e-commerce & logistics, agriculture, and healthcare.

Why the Market Is Growing: From Sustainability Messaging to Verified Disposal Outcomes

FMI observes that buyers are moving beyond generic sustainability claims and now require certified home compostability (such as TUV Austria OK Compost Home), which is reshaping procurement in retail and food service. This shift is motivating converters to broaden offerings in PLA and PHA, increasingly leveraging agricultural byproducts such as corn starch and sugarcane bagasse to support scale and feedstock diversification.

FMI further notes that compostable packaging is becoming strategically important in food waste systems because food-soiled plastic is difficult to recycle, making compostable formats better aligned with organic waste collection and diversion goals.

Operational Reality Check: What Changes When Brands Switch to Biodegradables?

FMI’s report highlights three practical considerations that are reshaping manufacturing and supply chain practices:

Shelf-Life and Inventory Discipline Become Non-Negotiable

Unlike petrochemical plastics that can sit in warehouses for extended periods, many biodegradable resins—especially starch-based and PHA—are hygroscopic and have finite shelf lives. FMI notes that suppliers must implement strict FIFO protocols and humidity-controlled storage to prevent premature breakdown that can cause defects during extrusion.

Processing Adjustments Are Required When Moving from PE to PLA

FMI emphasizes that PLA has a lower heat distortion temperature than PE or PP, requiring manufacturers to adjust film-blowing conditions, retrofit cooling systems, or modify screw geometries to avoid polymer degradation from shear heat—potentially increasing initial retrofit capital expenditure.

Standards Fragmentation Drives Multi-Region Certification Strategies

Compostability compliance differs across markets, with standards referenced in the report including ASTM D6400 (USA), EN 13432 (Europe), and AS 4736 (Australia). FMI notes that manufacturers are responding through multi-region certification and clearer on-pack labeling (e.g., BPI logo or Seedling logo) to ensure acceptance in local organic waste streams and to avoid greenwashing penalties.

Profitability Signals: What Winning Operators Measure Differently

EBITDA Margin: Tight Today, Expanding with Scale

FMI notes that EBITDA margins for biodegradable packaging firms typically range 10% to 18%, often tighter than traditional plastics due to higher agricultural feedstock costs. Margins improve as scale grows and fermentation technologies for PHAs become more efficient—especially when companies secure long-term supply contracts to hedge agricultural price spikes.

Inventory Turnover: Designed-to-Degrade Materials Need Faster Flow

Because biodegradable materials can degrade in storage, FMI highlights inventory turnover as a key operating metric, with efficient manufacturers targeting 8x to 10x turnover to protect resin freshness and avoid moisture-driven performance loss.

Production Cycle Time: Longer Cooling and Crystallization Phases

FMI reports that production cycle times can be 15–20% longer for bioplastics than for conventional polyolefins, especially with semi-crystalline PLA. Optimizing throughput while maintaining clarity for fresh food packaging is becoming a key balancing act, often supported by nucleating strategies.

Segment Outlook: PLA and Food Packaging Anchor Revenue

PLA-Based Packaging Leads (41% Share)

FMI estimates PLA-based packaging holds 41% share in 2026, supported by commercial availability, clarity, and PET-like mechanical performance—especially for cold food storage, blister packs, and cups. PLA’s role as a scalable, “drop-in” solution for existing thermoforming infrastructure reinforces its leadership.

Food Packaging Dominates (40% Share)

Food packaging represents 40.0% of market share in 2026, reflecting the urgent need to manage food contamination within waste systems. Compostable packaging is particularly suited for organic waste collection, and high-volume consumption supports steady demand for bioplastic converters.

Home Compostable Leads Functionality (42% Share)

FMI notes that the leading functionality is home compostable (42.0%), reflecting decentralized waste management adoption and inconsistent access to industrial composting in many regions—driving demand for formulations that break down at ambient temperatures.

Growth by Country: China and India Lead Acceleration

FMI’s country outlook underscores the influence of policy and waste systems:

• China: 9.1% CAGR — driven by plastics bans and large-scale adoption of degradable alternatives
• India: 8.9% CAGR — supported by single-use plastic bans and expansion of agri-waste processing for feedstock
• Germany: 6.7% CAGR — sustained by high certification standards and strong organic recycling focus
• United States: 6.4% CAGR — supported by composting access expansion and food waste diversion efforts
• Japan: 4.5% CAGR — shaped by resource circulation initiatives and marine-biodegradable material investment

Competitive Landscape: Vertical Integration and Fermentation IP Define Advantage

FMI finds that market participants are increasingly focusing on vertical integration to control biological feedstock cost and quality. Investment is rising in polymerization capacity and proprietary blends that combine different performance characteristics (e.g., PBAT toughness with PLA rigidity). The report also notes growing acquisition interest in biotechnology startups to access microbial fermentation IP for PHA production, and increased collaboration with major CPG brands to pilot closed-loop composting systems.

Get Access of Full Report:  https://www.futuremarketinsights.com/checkout/323 

Related Reports:

• Biodegradable Food Packaging Market: https://www.futuremarketinsights.com/reports/biodegradable-food-packaging-market
• Biodegradable Paper and Plastic Packaging Market: https://www.futuremarketinsights.com/reports/biodegradable-paper-and-plastic-packaging-market
• Demand for Biodegradable Food Packaging in USA: https://www.futuremarketinsights.com/reports/united-states-biodegradable-food-packaging-market

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Delaware, USA, with a global delivery center in India and offices in the UK and UAE, FMI delivers actionable insights to businesses across industries including automotive, technology, consumer products, manufacturing, energy, and chemicals.

An ESOMAR-certified research organization, FMI provides custom and syndicated market reports and consulting services, supporting both Fortune 1,000 companies and SMEs. Its team of 300+ experienced analysts ensures credible, data-driven insights to help clients navigate global markets and identify growth opportunities.

For Press & Corporate Inquiries
Rahul Singh
AVP – Marketing and Growth Strategy 
Future Market Insights, Inc.
+91 8600020075
For Sales – sales@futuremarketinsights.com
For Media – Rahul.singh@futuremarketinsights.com
For web – https://www.futuremarketinsights.com/

Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/biodegradable-packaging-market-to-reach-usd-24-2b-by-2036-6-1-cagr–pla-leads-41-and-food-packaging-tops-demand-40–growth-hotspots-china-india–germany-302692439.html

SOURCE Future Market Insights

Japan’s Ministry of Health, Labour and Welfare (MHLW) Approves PreemieFort® Enteral Solution as Prescription Medicine in the NICU 

DUARTE, Calif., Feb. 19, 2026 /PRNewswire/ — Prolacta Bioscience® today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved PreemieFort® Enteral Solution, a 100% human milk-based fortifier, as a prescription drug for very low birth weight infants, infants with congenital gastrointestinal disorders or congenital heart diseases, and those recovering from gastrointestinal surgery. This regulatory milestone was achieved in partnership with the Clinigen Group, which serves as Marketing Authorization Holder and distributor in Japan. PreemieFort is currently marketed under the brand name “Humavant” outside of the U.S., Canada, and Japan.  

The landmark regulatory decision validates the critical role of Prolacta’s 100% human milk-based fortifiers for the most fragile infants and sets a powerful precedent for neonatal intensive care units (NICUs) worldwide.  

“Japan’s approval of PreemieFort as a prescription drug reflects the strength of the clinical evidence and the pharmaceutical grade processing that stands up to the rigor of Japan’s stringent regulatory and quality requirements,” said Scott Elster, CEO of Prolacta Bioscience. ”The pivotal Japanese clinical study adds to the extensive evidence supporting the benefits of Prolacta’s exclusive human milk-based diet for critically ill and fragile premature infants.”   

Clinical evidence generated in Japan from the JASMINE trial (“A Randomized, Controlled Study to Assess Growth and Safety of the Exclusive Human Milk Diet (EHMD) in Very Low Birth Weight (VLBW) Infants”) informed Japan’s world-class Pharmaceuticals and Medical Devices Agency’s (PMDA) review.  The Japanese-led phase III, randomized, controlled, open-label, multicenter trial evaluated growth and safety associated with Prolacta’s 100% human milk-based fortifiers, demonstrating significantly better growth in VLBW infants with no change in morbidity or mortality. 

Japan is recognized as a global leader in neonatal care, with among the highest preterm survival rates and lowest rates of necrotizing enterocolitis (NEC),^1,2 a life-threatening intestinal disease primarily affecting premature infants. By granting pharmaceutical approval to PreemieFort, Japan is affirming that Prolacta’s human milk-based fortifiers, free from cow milk, are not simply a nutritional choice but an Rx medicine in the NICU.   

Japan’s approval includes three Prolacta products — PreemieFort Enteral Solution 6, PreemieFort Enteral Solution 8 (Humavant+6 and Humavant+8 human milk-based fortifiers outside the U.S., Canada, and Japan), and PreemieFort Enteral Solution CF (Humavant CR human milk caloric fortifier outside the U.S., Canada, and Japan) — which provide concentrated nutrition to support growth by delivering essential calories and nutrients, while retaining the highest level of human milk bioactivity.  

The approval demonstrates clinical confidence in the benefits and safety of PreemieFort human milk-based fortifiers across a wider range of vulnerable infants with complex nutritional needs.  

“In the NICU, what we feed our smallest patients can influence their entire life,” said Kate Tauber, MD, MA, professor of pediatrics and director of the Human Milk Program at Bernard and Millie Duker Children’s Hospital. “Human milk-based fortifiers should be held to the same expectations as other therapies, consistent, tightly controlled, and safe. Prolacta’s commitment to pharmaceutical-quality manufacturing requirements helps protect vulnerable infants and supports better outcomes.” 

Prolacta maintains the industry’s strictest quality and safety standards for screening, testing, and processing donor milk — standards that extend through pharmaceutical grade product manufacturing. Together, these controls earned Japan’s prescription drug approval, one of the world’s highest regulatory benchmarks.

About Prolacta Bioscience
Prolacta Bioscience® is the global leader in human milk-based nutrition, dedicated to improving health outcomes for critically ill and premature infants. The company’s 100% human milk-based fortifiers and formulas have been used in more than 125,000 vulnerable premature infants worldwide.³ In a global first, Japan granted Prolacta’s PreemieFort® fortifiers prescription drug status in late 2025 for very low birth weight infants, infants with congenital gastrointestinal disorders or congenital heart diseases, and those recovering from gastrointestinal surgery. Prolacta operates pharmaceutical-grade human milk processing facilities and maintains the industry’s strictest quality and safety standards, with more than 20 tests to screen donor milk and the use of vat pasteurization to inactivate pathogens and ensure safety. Its vat pasteurization also preserves the bioactive components of human milk that support immune protection, gut development, and growth — benefits that are especially important for premature and medically fragile infants.^4-6  Vat pasteurization keeps human milk closer to its natural state than other processing methods, while still ensuring safety.  Prolacta has built a secure, independent donor milk supply chain supported by long-term partnerships with thousands of rigorously screened donors, ensuring ample supply to meet NICU demand. Prolacta’s products have been evaluated in over 30 peer-reviewed clinical studies, demonstrating the short- and long-term health benefits of its patented human milk-based fortifiers and formulas. Learn more online or at X, Instagram, Facebook, TikTok, and LinkedIn. 

Media Contact:
Loren Kosmont  
Lkosmont@prolacta.com
310-721-9444 

References  

1. Kusuda S, Bennett MV, Gould JB, et al. Comparative analysis of necrotizing enterocolitis in preterm infants born in Japan and born to mothers of Japanese ethnicity in California. Sci Rep. 2025;15:9943. doi:10.1038/s41598-025-92393-y
2. Isayama T. The clinical management and outcomes of extremely preterm infants in Japan: past, present, and future. Transl Pediatr. 2019;8(3):199-211. doi:10.21037/tp.2019.07.10 
3. Data on file; estimated number of premature infants fed Prolacta’s products from January 2007 to May 2025. 
4. Ozturk G, Paviani B, Rai R, et al. Investigating milk fat globule structure, size, and functionality after thermal processing and homogenization of human milk. Foods. 2024;13(8):1242. doi:10.3390/foods13081242 
5. Liang N, Koh J, Kim BJ, et al. Structural and functional changes of bioactive proteins in donor human milk treated by vat-pasteurization, retort sterilization, ultra-high-temperature sterilization, freeze-thawing and homogenization. Front Nutr. Published online September 15, 2022. doi:10.3389/fnut.2022.926814 
6. Meredith-Dennis L, Xu G, Goonatilleke E, Lebrilla CB, Underwood MA, Smilowitz JT. Composition and variation of macronutrients, immune proteins, and human milk oligosaccharides in human milk from nonprofit and commercial milk banks. J Hum Lact. 2018;34(1):120-129. doi:10.1177/0890334417710635 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/a-world-first-in-neonatal-care-japan-approves-prolacta-biosciences-100-human-milk-based-fortifiers-as-a-prescription-drug-for-vulnerable-infants-302691997.html

SOURCE Prolacta Bioscience

Aims to help create a sustainable society and maximize societal well-being by promoting the Ten Principles of the UNGC

TOKYO, Feb. 19, 2026 /PRNewswire/ — transcosmos today announced that it has signed the United Nations Global Compact (UNGC), an initiative proposed by the United Nations, and was registered as a participating company effective February 5, 2026.

The UNGC is the world’s largest corporate sustainability initiative, bringing together the United Nations and the private sector (companies and organizations) to help create a healthy global society. It is a voluntary framework through which companies and organizations exercise responsible and creative leadership to achieve sustainable growth as responsible corporate citizens. 

The UNGC asks participating companies and organizations to support and continuously advance the implementation of the Ten Principles of the UNGC—related to the protection of human rights, the elimination of unfair labour practices, environmental responsibility, and the prevention of corruption—through commitments made by their CEOs.

• The Ten Principles of the United Nations Global Compact

Human Rights

Principle 1: Businesses should support and respect the protection of internationally proclaimed human rights; and

Principle 2: make sure that they are not complicit in human rights abuses.

Labour

Principle 3: Businesses should uphold the freedom of association and the effective recognition of the right to collective bargaining;

Principle 4: the elimination of all forms of forced and compulsory labour;

Principle 5: the effective abolition of child labour; and

Principle 6: the elimination of discrimination in respect of employment and occupation.

Environment

Principle 7: Businesses should support a precautionary approach to environmental challenges;

Principle 8: undertake initiatives to promote greater environmental responsibility; and

Principle 9: encourage the development and diffusion of environmentally friendly technologies.

Anti-Corruption

Principle 10: Businesses should work against corruption in all its forms, including extortion and bribery.

Guided by its fundamental management philosophy that client satisfaction is the true value of our company and that the growth of each of our employees creates the value that shapes our future, transcosmos is committed to helping create a sustainable society and maximizing the well-being of society as a whole by promoting the Ten Principles of the UNGC.

<transcosmos Sustainability Initiatives>

In 2021, transcosmos established the transcosmos SDGs Committee chaired by the Representative Director & Chairman, and put in place a framework specifically designed to execute its initiatives towards meeting social challenges and expectations with a focus on environmental, social and governance (ESG) criteria. In addition, with the purpose of creating a sustainable society and boosting the well-being of society as a whole, transcosmos has set out its fundamental sustainability policy.

Committed to our purpose of expanding our social impact as a business and ultimately maximizing the well-being of society as a whole through solving social challenges, we, transcosmos, are engaging in meaningful business activities to become a Sustainable Transformation (SX) Partner for all.

*transcosmos is a trademark or registered trademark of transcosmos inc. in Japan and other countries.
*Other company names and product or service names used here are trademarks or registered trademarks of respective companies.

• About transcosmos inc.

transcosmos launched its operations in 1966. Since then, we have united superior “people” with up-to-date “technology” to enhance the competitive strength of our clients by providing them with superior and valuable services. transcosmos currently offers services that support clients’ business processes focusing on both sales expansion and cost optimization through our 186 bases across 36 countries/regions with a focus on Asia, while continuously pursuing Operational Excellence. Furthermore, following the expansion of e-commerce market on the global scale, transcosmos provides a comprehensive One-Stop Global E-Commerce Services to deliver our clients’ excellent products and services to consumers in 46 countries/regions around the globe. transcosmos aims to be the “Global Digital Transformation Partner” of our clients, supporting the clients’ transformation by leveraging digital technology, responding to the ever-changing business environment. Visit us here https://www.trans-cosmos.co.jp/english/

View original content to download multimedia:https://www.prnewswire.com/news-releases/transcosmos-signs-the-united-nations-global-compact-302692210.html

SOURCE transcosmos inc.

Aims to help create a sustainable society and maximize societal well-being by promoting the Ten Principles of the UNGC

TOKYO, Feb. 19, 2026 /PRNewswire/ — transcosmos today announced that it has signed the United Nations Global Compact (UNGC), an initiative proposed by the United Nations, and was registered as a participating company effective February 5, 2026.

The UNGC is the world’s largest corporate sustainability initiative, bringing together the United Nations and the private sector (companies and organizations) to help create a healthy global society. It is a voluntary framework through which companies and organizations exercise responsible and creative leadership to achieve sustainable growth as responsible corporate citizens. 

The UNGC asks participating companies and organizations to support and continuously advance the implementation of the Ten Principles of the UNGC—related to the protection of human rights, the elimination of unfair labour practices, environmental responsibility, and the prevention of corruption—through commitments made by their CEOs.

• The Ten Principles of the United Nations Global Compact

Human Rights

Principle 1: Businesses should support and respect the protection of internationally proclaimed human rights; and

Principle 2: make sure that they are not complicit in human rights abuses.

Labour

Principle 3: Businesses should uphold the freedom of association and the effective recognition of the right to collective bargaining;

Principle 4: the elimination of all forms of forced and compulsory labour;

Principle 5: the effective abolition of child labour; and

Principle 6: the elimination of discrimination in respect of employment and occupation.

Environment

Principle 7: Businesses should support a precautionary approach to environmental challenges;

Principle 8: undertake initiatives to promote greater environmental responsibility; and

Principle 9: encourage the development and diffusion of environmentally friendly technologies.

Anti-Corruption

Principle 10: Businesses should work against corruption in all its forms, including extortion and bribery.

Guided by its fundamental management philosophy that client satisfaction is the true value of our company and that the growth of each of our employees creates the value that shapes our future, transcosmos is committed to helping create a sustainable society and maximizing the well-being of society as a whole by promoting the Ten Principles of the UNGC.

<transcosmos Sustainability Initiatives>

In 2021, transcosmos established the transcosmos SDGs Committee chaired by the Representative Director & Chairman, and put in place a framework specifically designed to execute its initiatives towards meeting social challenges and expectations with a focus on environmental, social and governance (ESG) criteria. In addition, with the purpose of creating a sustainable society and boosting the well-being of society as a whole, transcosmos has set out its fundamental sustainability policy.

Committed to our purpose of expanding our social impact as a business and ultimately maximizing the well-being of society as a whole through solving social challenges, we, transcosmos, are engaging in meaningful business activities to become a Sustainable Transformation (SX) Partner for all.

*transcosmos is a trademark or registered trademark of transcosmos inc. in Japan and other countries.
*Other company names and product or service names used here are trademarks or registered trademarks of respective companies.

• About transcosmos inc.

transcosmos launched its operations in 1966. Since then, we have united superior “people” with up-to-date “technology” to enhance the competitive strength of our clients by providing them with superior and valuable services. transcosmos currently offers services that support clients’ business processes focusing on both sales expansion and cost optimization through our 186 bases across 36 countries/regions with a focus on Asia, while continuously pursuing Operational Excellence. Furthermore, following the expansion of e-commerce market on the global scale, transcosmos provides a comprehensive One-Stop Global E-Commerce Services to deliver our clients’ excellent products and services to consumers in 46 countries/regions around the globe. transcosmos aims to be the “Global Digital Transformation Partner” of our clients, supporting the clients’ transformation by leveraging digital technology, responding to the ever-changing business environment. Visit us here https://www.trans-cosmos.co.jp/english/

View original content to download multimedia:https://www.prnewswire.com/news-releases/transcosmos-signs-the-united-nations-global-compact-302692210.html

SOURCE transcosmos inc.

Aims to help create a sustainable society and maximize societal well-being by promoting the Ten Principles of the UNGC

TOKYO, Feb. 19, 2026 /PRNewswire/ — transcosmos today announced that it has signed the United Nations Global Compact (UNGC), an initiative proposed by the United Nations, and was registered as a participating company effective February 5, 2026.

The UNGC is the world’s largest corporate sustainability initiative, bringing together the United Nations and the private sector (companies and organizations) to help create a healthy global society. It is a voluntary framework through which companies and organizations exercise responsible and creative leadership to achieve sustainable growth as responsible corporate citizens. 

The UNGC asks participating companies and organizations to support and continuously advance the implementation of the Ten Principles of the UNGC—related to the protection of human rights, the elimination of unfair labour practices, environmental responsibility, and the prevention of corruption—through commitments made by their CEOs.

• The Ten Principles of the United Nations Global Compact

Human Rights

Principle 1: Businesses should support and respect the protection of internationally proclaimed human rights; and

Principle 2: make sure that they are not complicit in human rights abuses.

Labour

Principle 3: Businesses should uphold the freedom of association and the effective recognition of the right to collective bargaining;

Principle 4: the elimination of all forms of forced and compulsory labour;

Principle 5: the effective abolition of child labour; and

Principle 6: the elimination of discrimination in respect of employment and occupation.

Environment

Principle 7: Businesses should support a precautionary approach to environmental challenges;

Principle 8: undertake initiatives to promote greater environmental responsibility; and

Principle 9: encourage the development and diffusion of environmentally friendly technologies.

Anti-Corruption

Principle 10: Businesses should work against corruption in all its forms, including extortion and bribery.

Guided by its fundamental management philosophy that client satisfaction is the true value of our company and that the growth of each of our employees creates the value that shapes our future, transcosmos is committed to helping create a sustainable society and maximizing the well-being of society as a whole by promoting the Ten Principles of the UNGC.

<transcosmos Sustainability Initiatives>

In 2021, transcosmos established the transcosmos SDGs Committee chaired by the Representative Director & Chairman, and put in place a framework specifically designed to execute its initiatives towards meeting social challenges and expectations with a focus on environmental, social and governance (ESG) criteria. In addition, with the purpose of creating a sustainable society and boosting the well-being of society as a whole, transcosmos has set out its fundamental sustainability policy.

Committed to our purpose of expanding our social impact as a business and ultimately maximizing the well-being of society as a whole through solving social challenges, we, transcosmos, are engaging in meaningful business activities to become a Sustainable Transformation (SX) Partner for all.

*transcosmos is a trademark or registered trademark of transcosmos inc. in Japan and other countries.
*Other company names and product or service names used here are trademarks or registered trademarks of respective companies.

• About transcosmos inc.

transcosmos launched its operations in 1966. Since then, we have united superior “people” with up-to-date “technology” to enhance the competitive strength of our clients by providing them with superior and valuable services. transcosmos currently offers services that support clients’ business processes focusing on both sales expansion and cost optimization through our 186 bases across 36 countries/regions with a focus on Asia, while continuously pursuing Operational Excellence. Furthermore, following the expansion of e-commerce market on the global scale, transcosmos provides a comprehensive One-Stop Global E-Commerce Services to deliver our clients’ excellent products and services to consumers in 46 countries/regions around the globe. transcosmos aims to be the “Global Digital Transformation Partner” of our clients, supporting the clients’ transformation by leveraging digital technology, responding to the ever-changing business environment. Visit us here https://www.trans-cosmos.co.jp/english/

View original content to download multimedia:https://www.prnewswire.com/news-releases/transcosmos-signs-the-united-nations-global-compact-302692210.html

SOURCE transcosmos inc.

A Houston physician turns her private infertility journal into a national wake-up call, sparking urgent conversations about medical dismissal, maternal health disparities, and the voices Black women refuse to silence.

HOUSTON, Feb. 18, 2026 /PRNewswire/ — In December, Dr. Chinyere “Dr. Chi” Johnson took a bold leap and released a video series detailing her infertility journey. Within the journal, she shared her process in becoming pregnant, including loss and experiencing medical dismissal. What was intended to be a vulnerable private video journal became, instead, a story she shared online with her followers. To her surprise, within the first 30 days of the series’ release, it garnered 10 million plus views across social media. What began as an online video journal became a broader conversation about how Black women are treated in healthcare.

Dr. Chi is a Houston-based hospitalist, mental health advocate, and former Division I athlete accustomed to discipline and structure. Yet when she raised concerns about her own health, she met a reality many Black women describe; symptoms minimized, concerns delayed, and persistent questions brushed aside.

“I knew the system,” Dr. Chi says. “But knowing it doesn’t prevent you from experiencing it.”

Her story reflects patterns backed by data:

The Centers for Disease Control and Prevention report that Black women in the United States are nearly three times more likely to die from pregnancy-related causes than white women, disparities that experts often link to delayed recognition of complications and inequitable care. A 2016 study published in the Proceedings of the National Academy of Sciences found that some medical trainees and students held false beliefs about biological differences between Black and white patients, affecting pain assessment and treatment recommendations. Research from the Commonwealth Fund shows Black women are more likely than white women to report that medical providers did not listen carefully or take their concerns seriously.

Dr. Chi’s series documents more than infertility. It outlines the strain of delayed answers, pregnancy loss, and navigating fertility treatment while practicing medicine herself. The response was instant. Thousands of women shared similar experiences. Among the messages were deeply private reflections from women who had been silently navigating infertility for years. One woman wrote:

“I began my infertility journey in 2021 and stepped away after nearly two years. There were occasions when I questioned whether motherhood was meant for me. Still deep down, I know that is not my story, and I keep holding on to hope. Seeing Dr. Chi speak out reminded me that I’m not alone, that this isn’t just my struggle. It’s more common than we talk about. Over the next 30 days, I’m choosing to face my emotions and work through the depression that comes with wanting to be a mother and not knowing what’s next.”

Rather than centering blame, Dr. Chis focused on improvement. She advocates for women who feel unheard in clinical settings and provides educational tools that help them ask informed questions and navigate their care with confidence. Ten million views in one month signals a deeper issue. Dr. Chi continues to practice medicine while urging the profession to listen more closely, document more carefully, and respond more decisively.

For media inquiries, or to schedule an interview with Dr. Chinyere “Dr. Chi” Johnson for both in-person and Zoom interviews please contact Innovating Marketing Group at info@innovatingmarketinggroup.com or call 346-980-9062.

About Dr. Chinyere “Dr. Chi” Johnson

Dr. Chinyere “Dr. Chi” Okpaleke, MD, is a Houston-based family medicine physician, mental health advocate, and founder who understands what it means to sit on both sides of the exam table. After years of caring for patients, she found herself navigating infertility, loss, and the frustration of not feeling heard within the very system she works in. Instead of staying silent, she shared her journey publicly. Her candid video series reached more than 10 million views in just 30 days and sparked honest conversations about bias in healthcare, burnout, and the emotional weight women quietly carry.

Known for her warmth, transparency, and practical wisdom, Dr. Chi blends medical expertise with lived experience. Through speaking, media, and community work, she empowers women to advocate for their health, protect their mental well-being, and know that they are not alone.

Press Contact:

LaToya F Hurley
3469809062
Contact Us
http://www.Innovatingmarketinggroup.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10-million-views-in-30-days-dr-chis-viral-series-shines-light-on-infertility-and-dismissed-symptoms-black-women-face-302692027.html

SOURCE Dr. Chinyere “Dr. Chi” Johnson

A Houston physician turns her private infertility journal into a national wake-up call, sparking urgent conversations about medical dismissal, maternal health disparities, and the voices Black women refuse to silence.

HOUSTON, Feb. 18, 2026 /PRNewswire/ — In December, Dr. Chinyere “Dr. Chi” Johnson took a bold leap and released a video series detailing her infertility journey. Within the journal, she shared her process in becoming pregnant, including loss and experiencing medical dismissal. What was intended to be a vulnerable private video journal became, instead, a story she shared online with her followers. To her surprise, within the first 30 days of the series’ release, it garnered 10 million plus views across social media. What began as an online video journal became a broader conversation about how Black women are treated in healthcare.

Dr. Chi is a Houston-based hospitalist, mental health advocate, and former Division I athlete accustomed to discipline and structure. Yet when she raised concerns about her own health, she met a reality many Black women describe; symptoms minimized, concerns delayed, and persistent questions brushed aside.

“I knew the system,” Dr. Chi says. “But knowing it doesn’t prevent you from experiencing it.”

Her story reflects patterns backed by data:

The Centers for Disease Control and Prevention report that Black women in the United States are nearly three times more likely to die from pregnancy-related causes than white women, disparities that experts often link to delayed recognition of complications and inequitable care. A 2016 study published in the Proceedings of the National Academy of Sciences found that some medical trainees and students held false beliefs about biological differences between Black and white patients, affecting pain assessment and treatment recommendations. Research from the Commonwealth Fund shows Black women are more likely than white women to report that medical providers did not listen carefully or take their concerns seriously.

Dr. Chi’s series documents more than infertility. It outlines the strain of delayed answers, pregnancy loss, and navigating fertility treatment while practicing medicine herself. The response was instant. Thousands of women shared similar experiences. Among the messages were deeply private reflections from women who had been silently navigating infertility for years. One woman wrote:

“I began my infertility journey in 2021 and stepped away after nearly two years. There were occasions when I questioned whether motherhood was meant for me. Still deep down, I know that is not my story, and I keep holding on to hope. Seeing Dr. Chi speak out reminded me that I’m not alone, that this isn’t just my struggle. It’s more common than we talk about. Over the next 30 days, I’m choosing to face my emotions and work through the depression that comes with wanting to be a mother and not knowing what’s next.”

Rather than centering blame, Dr. Chis focused on improvement. She advocates for women who feel unheard in clinical settings and provides educational tools that help them ask informed questions and navigate their care with confidence. Ten million views in one month signals a deeper issue. Dr. Chi continues to practice medicine while urging the profession to listen more closely, document more carefully, and respond more decisively.

For media inquiries, or to schedule an interview with Dr. Chinyere “Dr. Chi” Johnson for both in-person and Zoom interviews please contact Innovating Marketing Group at info@innovatingmarketinggroup.com or call 346-980-9062.

About Dr. Chinyere “Dr. Chi” Johnson

Dr. Chinyere “Dr. Chi” Okpaleke, MD, is a Houston-based family medicine physician, mental health advocate, and founder who understands what it means to sit on both sides of the exam table. After years of caring for patients, she found herself navigating infertility, loss, and the frustration of not feeling heard within the very system she works in. Instead of staying silent, she shared her journey publicly. Her candid video series reached more than 10 million views in just 30 days and sparked honest conversations about bias in healthcare, burnout, and the emotional weight women quietly carry.

Known for her warmth, transparency, and practical wisdom, Dr. Chi blends medical expertise with lived experience. Through speaking, media, and community work, she empowers women to advocate for their health, protect their mental well-being, and know that they are not alone.

Press Contact:

LaToya F Hurley
3469809062
Contact Us
http://www.Innovatingmarketinggroup.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10-million-views-in-30-days-dr-chis-viral-series-shines-light-on-infertility-and-dismissed-symptoms-black-women-face-302692027.html

SOURCE Dr. Chinyere “Dr. Chi” Johnson